Is stories |
Insys Therapeutics: FDA Approves Treatment for AIDS Symptoms
Wall Street Journal Insys Therapeutics Inc. INSY 4.10 % said Tuesday that the U.S. Food and Drug Administration approved its Dronabinol oral solution for treating certain conditions related to cancer and AIDS, nearly two years after the regulator rejected an earlier ... Insys Therapeutics Announces FDA Approval of Syndros™ FDA approves Insys Therapeutics' Syndros for anorexia weight loss and CINV; shares ahead 21% premarket Insys Therapeutics, Inc. (NASDAQ:INSY) Consolidated Diluted EPS Stands At $0.7724 |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHmWTbnvcYLNjvHcnAS--eluNvcUg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779149202405&ei=nq57V_iePIWc3QHi85-IDA&url=http://www.wsj.com/articles/insys-therapeutics-fda-approves-treatment-for-aids-symptoms-1467720726
via IFTTT
No comments:
Post a Comment